BATTAGLIA, GLORIANA
 Distribuzione geografica
Continente #
NA - Nord America 3.843
AS - Asia 2.850
EU - Europa 1.268
SA - Sud America 484
AF - Africa 147
Continente sconosciuto - Info sul continente non disponibili 79
OC - Oceania 3
Totale 8.674
Nazione #
US - Stati Uniti d'America 3.719
SG - Singapore 1.042
CN - Cina 825
BR - Brasile 377
SE - Svezia 336
VN - Vietnam 325
IE - Irlanda 324
HK - Hong Kong 198
TR - Turchia 166
IT - Italia 105
FR - Francia 103
BD - Bangladesh 88
ZA - Sudafrica 83
NL - Olanda 78
DE - Germania 64
CA - Canada 60
GB - Regno Unito 54
RU - Federazione Russa 50
FI - Finlandia 43
IN - India 36
AR - Argentina 35
CI - Costa d'Avorio 30
MX - Messico 27
UA - Ucraina 26
AT - Austria 20
CO - Colombia 19
TH - Thailandia 18
IQ - Iraq 16
VE - Venezuela 16
JP - Giappone 15
EC - Ecuador 12
ES - Italia 12
PL - Polonia 11
PH - Filippine 10
AE - Emirati Arabi Uniti 9
BE - Belgio 9
CL - Cile 9
ID - Indonesia 9
IL - Israele 9
JO - Giordania 9
MA - Marocco 9
PK - Pakistan 9
SA - Arabia Saudita 8
KR - Corea 7
PA - Panama 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
BO - Bolivia 6
CR - Costa Rica 6
JM - Giamaica 6
KE - Kenya 6
PE - Perù 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
HR - Croazia 4
IR - Iran 4
LY - Libia 4
MY - Malesia 4
OM - Oman 4
PS - Palestinian Territory 4
AL - Albania 3
AU - Australia 3
EE - Estonia 3
NI - Nicaragua 3
NP - Nepal 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
BB - Barbados 2
BY - Bielorussia 2
EG - Egitto 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
HT - Haiti 1
KH - Cambogia 1
Totale 8.587
Città #
Chandler 524
Ashburn 508
Singapore 494
Santa Clara 360
Dublin 324
San Jose 309
Hong Kong 186
Beijing 164
Dallas 149
Dearborn 130
Izmir 127
Nanjing 111
Ho Chi Minh City 106
New York 100
Boardman 94
Council Bluffs 90
Los Angeles 83
Johannesburg 79
Hanoi 78
Princeton 70
Lauterbourg 57
Shanghai 50
Wilmington 42
Columbus 41
Moscow 35
Helsinki 34
Buffalo 31
Hebei 30
São Paulo 30
Nanchang 29
Abidjan 27
Shenyang 27
Kocaeli 26
Toronto 24
Milan 23
Munich 21
Seattle 21
Changsha 20
The Dalles 20
Guangzhou 19
Hangzhou 19
Kunming 19
Tianjin 18
Vienna 18
Atlanta 17
Frankfurt am Main 17
Jiaxing 17
Haiphong 16
Rio de Janeiro 15
Rome 15
Hefei 14
North Bergen 14
Belo Horizonte 13
Jinan 13
Montreal 13
Jacksonville 12
San Mateo 12
Tokyo 12
Zhengzhou 12
Chicago 11
London 11
Da Nang 10
Fremont 10
Norwalk 10
Orem 10
San Francisco 10
Brussels 9
Turku 9
Houston 8
Porto Alegre 8
Stockholm 8
Amman 7
Baghdad 7
Bangkok 7
Boston 7
Brooklyn 7
Campinas 7
Curitiba 7
Denver 7
Hải Dương 7
Panama City 7
Warsaw 7
Ann Arbor 6
Chennai 6
Naples 6
Newark 6
Poplar 6
Riyadh 6
Tashkent 6
Brasília 5
Dhaka 5
Kingston 5
Miami 5
Nuremberg 5
Phoenix 5
Salvador 5
Washington 5
Wuhan 5
Bogotá 4
Borås 4
Totale 5.265
Nome #
[Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis] 232
H2-blockers in the treatment of ulcer disease in the elderly 206
Long-term treatment for gastric and duodenal ulcer 189
Individualized treatment of duodenal ulcer disease. A pilot study 181
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 171
Clinical markers of slow healing and relapsing gastric ulcer 167
[Clinical usefulness of the blood gastrin curve after protein meal in duodenal ulcer] 166
[Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer] 166
Cimetidine, ranitidine, and pirenzepine in the treatment of duodenal ulcer: A six-month low-dose treatment period followed by a six-month observation period 162
[Clinical usefulness of endoscopy of the upper digestive tract in the aged] 161
800 mg of cimetidine versus 300 mg of ranitidine at bedtime in the short-term treatment of duodenal ulcer: A cost/benefit study 159
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 158
Comparison of 150 mg nizatidine BID or 300 mg at bedtime, and 150 mg ranitidine BID in the treatment of gastric ulcer--an 8-week randomized, double-blind multicentre study 156
Azithromycin for the cure of Helicobacter pylori infection 156
TERAPIA DI MANTENIMENTO PER UN ANNO CON ANTI-H2 NELL'ULCERA PEPTICA DELL'ANZIANO: IMPORTANZA DELLA SINTOMATOLOGIA COME MARKER DI RECIDIVA 154
Gastric and duodenal ulcer in the same patient 149
Cefixime for the eradication of helicobacter pylori 146
Compliance with therapy for ulcer disease: clinical experience and review of the literature 145
Cure of Helicobacter pylori-positive active duodenal ulcer patients: double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy 145
CARATTERISTICHE EPIDEMIOLOGICHE, CLINICHE E FUNZIONALI IN PAZIENTI CON SANGUINAMENTO DA ULCERA DUODENALE 143
A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study 142
Mucosal pepsin and group I pepsinogen concentration in peptic ulcer patients with a history of bleeding 141
Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs 136
A preliminary report on Helicobacter pylori and antral gastrin concentration in patients with duodenal ulcer 135
Early drop in anti Helicobacter pylori IgG titre after eradication therapy with clarithromycin 133
Gastric ulcer and stomach aging: Pathophysiology and clinical implications 129
H2antagonists and gastric ulcer: A multicenter, randomized, double-blind, controlled study comparing nizatidine with ranitidine 128
Clarithromycin for the cure of Helicobacter pylori infection: One or two weeks of treatment 128
Blood pepsinogen as a subclinical marker for duodenal ulcer 126
Milk consumption and duodenal ulcer outcome: A short- and long-term study 126
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: One or two weeks? 126
A therapeutic strategy after a first ineffective cure of H. pylori infection. One-centre experience on 74 consecutive patients 125
LA BULBODUODENITE NON ULCEROSA: ASPETTI CLINICI E TRATTAMENTO FARMACOLOGICO 124
Disappearance of gallbladder wall lesions after treatment with ursodeozycolic acid 124
MODIFICAZIONI DELLA MUCOSA GASTRICA IN CORSO DI TRATTAMENTO DELLA MALATTIA ULCEROSA 124
Double, 14-day therapy with omeprazole and clarithromycin is not sufficiently effective for the cure of Helicobacter pylori infection. Comparison with two triple 7-day therapies 123
Fasting and post-prandial serum gastrin concentrations in peptic ulcer disease. Pathophysiological considerations in relationship to the different localization 122
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 120
ACIDO N-ACETILNEURAMINICO DOPO PENTAGASTRINA E SECRETINA IN SOGGETTI CON ULCERA DUODENALE E DISPEPSIA NON ULCEROSA 120
Gastric bicarbonate secretion in high-relapsing, smoking duodenal ulcer patients 115
Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? 115
Risk factors of duodenal ulcer bleeding: the role of smoking and nicotine 114
Hemorrhagic duodenal ulcer disease: Clinical and biochemical findings in a case-control pilot study 114
ULCERA PEPTICA E CIRROSI EPATICA. CONSIDERAZIONI CLINICO-EPIDEMIOLOGISCHE 112
Helicobacter pylori infection, cigarette smoking and alcohol consumption. A histological and clinical study on 286 subjects 111
EFFETTO DELLA NIZATIDINA E DEL MISOPROSTOL SULL'ATTIVITA PEPTICA E SUL MUCO GASTRICO SOLUTO 108
The appearance of gord in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: A 4 year prospective study 106
The natural history of duodenal ulcer disease 106
Sucralfate and cisapride in the treatment of duodenogastric reflux and dyspepsia: A randomized study 106
Studio scintigrafico del tempo di svuotamento gastrico in pazienti con ulcera duodenale 105
Serum pepsinogen A and C levels: A follow-up study on 476 patients after Helicobacter pylori eradication 99
Ulcera gastrica, ulcera duodenale e gruppi sanguigni "maggiori e minori". Aspetti epidemiologici, correlazioni funzionali, implicazioni cliniche 99
Personality traits and gastric acid secretion in ulcer disease 98
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly 97
Serum pepsinogens A and C in monitoring Helicobacter pylori (Hp) status after the cure: A prospective 4 year study 97
Sucralfate gel versus ranitidine in the treatment of gastroesophageal reflux disease: A controlled study 95
Ranitidine bismuthate citrate as a second step for the eradication of Helicobacter pylori 93
Strategy for the retreatment of failed Helicobacter pylori eradication therapy: a case series 92
Sucralfate for preventing gastric ulcer relapse: A controlled prospective study 91
Helicobacter pylori (Hp) eradication in functional dyspepsia: A prospective randomized 3 year study 90
High IgE serum levels and "peptic" ulcers: clinical and functional approach 89
Helicobacter pylori eradication: Can a successful therapy be predicted? 89
Lymphoid follicles in gastric mucosa of Helicobacter pylori infected patients regress after eradication treatment 86
Optimal PPI-based triple therapy for the cure of Helicobacter pylori infection: a single center comparison of four 14-day schedules 83
Valutazione clinica della gastrinemia basale nella malattia ulcerosa 82
Early fall of anti Helicobacter pylori IgG in eradicated patients with non-ulcer dyspepsia 79
One year follow-up of malt lymphoma of the stomach: Evidence for the need of an accurate diagnostic management 72
Helicobacter pylori and Serum Pepsinogen A, Pepsinogen C, and Gastrin: A Methodological Note 70
Seasonal Fluctuations in Peptic Ulcer Bleeding: An Italian Experience 62
LA TERAPIA DELLA MALATTIA ULCEROSA NELL'ANZIANO: STUDIO PROSPETTICO RANDOMIZZATO CON FARMACI ANTISECRETORI 55
Totale 8.674
Categoria #
all - tutte 30.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022251 0 0 0 0 14 2 3 25 18 15 28 146
2022/20231.461 133 149 131 132 95 184 7 122 415 6 71 16
2023/2024402 13 49 11 9 31 127 7 34 17 34 33 37
2024/20251.742 36 78 90 100 284 284 92 71 200 115 112 280
2025/20263.045 303 250 333 222 456 216 287 88 389 242 148 111
2026/2027767 115 160 184 266 42 0 0 0 0 0 0 0
Totale 8.674